Blalock Williams’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.4M Buy
10,220
+45
+0.4% +$45.6K 7.27% 1
2025
Q4
$10.9M Buy
10,175
+104
+1% +$99.4K 8.75% 1
2025
Q3
$7.68M Buy
10,071
+3
+0% +$2.23K 6.73% 1
2025
Q2
$7.85M Sell
10,068
-13
-0.1% -$10.1K 7.84% 1
2025
Q1
$8.33M Buy
10,081
+85
+0.9% +$70.7K 9.32% 1
2024
Q4
$7.72M Buy
+9,996
New +$8.28M 8.98% 1

Other funds holding LLY

Blalock Williams's LLY Position: Q1 2026 in Review

Blalock Williams increased its Eli Lilly (LLY) stake by 0.44% in Q1 2026, buying an estimated $45.6K and bringing the position to 10,220 shares worth $9.4M. The position accounts for 7.27% of the portfolio, ranked #1.

Blalock Williams first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $10.9M in Q4 2025. 4,358 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Blalock Williams held 10,220 shares of Eli Lilly worth $9.4M as of Q1 2026.
  • Blalock Williams bought 45 Eli Lilly shares in Q1 2026, an estimated $45.6K.
  • Eli Lilly made up 7.27% of Blalock Williams's portfolio in Q1 2026, its #1 holding.
  • Blalock Williams first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Blalock Williams's Eli Lilly position peaked at $10.9M in Q4 2025.
  • 4,358 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Blalock Williams's 13F filing for Q1 2026, filed 14 May 2026.